According to the CT A.G.'s Office, Cephalon may have been a little too aggressive in trying to expand sales of Actiq. Actiq is a lollipop-administered drug approved only to treat cancer pain.
According to reports, doctors ranging from neurologists to anesthesiologists have prescribed the drug for a range of pain conditions including migraines.
What is notable is this comment in an article found online: The use of Actiq for cancer patients may be less than 20 percent of total sales, and many of the sales are based on prescriptions from anesthesiologists, rehabilitation specialists and others. Source here.
